AI Procedure Guidance

About Rivanna Medical

Rivanna Medical is a private, commercial-stage medical device company leveraging a unified AI and 3D ultrasound platform to tackle two high-need clinical areas: spinal needle guidance and bedside fracture triage. The company has secured FDA clearance for its initial Accuro 3S device, validated its technology through government grants and clinical studies, and is pursuing 510(k) pathways for its next-generation products. With a combined total addressable market (TAM) exceeding $3.4 billion, Rivanna is positioned at the intersection of point-of-care ultrasound and AI-driven diagnostics, seeking strategic investment to scale its platform.

Therapeutic Areas